United Therapeutics CEO Martine Rothblatt disposes of USD 4.88 million in common shares
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised options for 9,500 shares at USD 117.76 on Oct. 7, 2026. A family trust sold 9,500 shares that day at weighted-average prices ranging from USD 542.7339 to USD 556.4848, ending with 324,443 shares.
1. Share transactions
Rothblatt exercised stock options for 9,500 United Therapeutics shares at USD 117.76 on Oct. 7, 2026. A family trust sold 9,500 shares that day at weighted-average prices ranging from USD 542.7339 to USD 556.4848; its holdings ended at 324,443 shares.
